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Abstract 
Introduction: Economically disadvantaged smokers not intending to stop may benefit from 
interventions aimed at reducing their smoking.  This study assessed the effects of a 
behavioural intervention promoting an increase in physical activity versus usual care in a 
pilot randomised controlled trial. 
Methods: Disadvantaged smokers who wanted to reduce but not quit were randomised to 
either a counselling intervention of up to 12 weeks to support smoking reduction and 
increased physical activity (n=49) or usual care (n=50). Data at 16 weeks were collected for 
various smoking and physical activity outcomes. Primary analyses consisted of an intention 
to treat analysis based on complete case data. Secondary analyses explored the impact of 
handling missing data. 
Results: Compared with controls, intervention smokers were more likely to initiate a quit 
attempt (36 v 10%; Odds Ratio 5.05, (95% CI: 1.10; 23.15)), and a greater proportion 
achieved ≥ 50% reduction in cigarettes smoked (63 v 32%; 4.21 (1.32; 13.39). Post-quit 
abstinence measured by exhaled carbon monoxide at 4 week follow-up showed promising 
differences between groups (23% v 6%; 4.91 (0.80; 30.24). No benefit of intervention on 
physical activity was found. Secondary analyses suggested that the standard missing data 
assumption of ‘missing’ being equivalent to ‘smoking’ may be conservative resulting in a 
reduced intervention effect. 
Conclusions:  A smoking reduction intervention for economically disadvantaged smokers 
which involved personal support to increase physical activity appears to be more effective 
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than usual care in achieving reduction and may promote cessation. The effect does not 
appear to be influenced by an increase in physical activity.
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INTRODUCTION 
Smoking is the biggest contributing factor to health inequalities 1, and although smokers 
from disadvantaged backgrounds (i.e. those of low-socioeconomic status) attempt to quit at 
the same rate as others their success in quitting is lower 2. This is leading to increasing 
disparities in smoking prevalence between the upper and lower social grades in the United 
Kingdom 3, with similar trends being observed in the United States 4, suggesting a need for 
interventions specifically designed for these groups 5.  
Good quality evidence for the effectiveness of smoking cessation interventions for 
disadvantaged groups is limited 6,7 and further research is needed on how best to both 
increase intervention reach and smoking cessation success 8. It is likely that a range of 
intervention options may be needed to increase reach and to reduce smoking prevalence, 
such as locating services in community settings with most need, developing roles for 
outreach workers (e.g., health trainers) 9, and developing multidimensional and complex 
behaviour change interventions that are specifically designed for disadvantaged groups 10. 
Smoking reduction may be a viable alternative to the traditional abrupt approach to 
smoking cessation 11. In the English Smoking Toolkit Study, 57 percent  of current smokers 
reported they were in the process of cutting down 3 with a variety of approaches being used 
12. Smokers who do not intend to quit in the next month, but cut down with nicotine 
replacement therapy (NRT), are more likely to make a quit attempt and be abstinent at 
follow-up 13 than those who do not cut down. Smoking reduction may increase the 
motivation to quit, which is highly predictive of quit attempts, and reduce smoking 
dependence, which is related to successful quitting 14. While NRT is popular as an aid for 
smoking reduction, 31% of smokers believed that sustained use of NRT was ‘very’ or ‘quite’ 
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harmful to health 15 and disadvantaged groups may be sceptical of the effectiveness of NRT 
in meeting their needs if they were to quit 16. Furthermore, stop smoking advisors and 
managers have expressed concern that combining NRT with smoking may have negative 
health consequences 17. There is clearly a need for further research on supporting smoking 
reduction for those who do not wish to use NRT, among both those who do wish to quit and 
those who don’t. Among those who do wish to quit, smoking reduction using 
pharmacotherapy and behavioural support appears to be as effective as abruptly quitting 11. 
A review of exercise interventions (versus usual care) as an aid for long-term smoking 
cessation 18 identified 16 randomised controlled trials, but all were among smokers who 
wished to quit, and most were methodologically limited. Of the seven which were 
adequately powered, three found significant increases in abstinence at the end of 
treatment, but only one reported increased abstinence rates at 12 month follow up. 
Variation in study length, type (e.g., structured group-based exercise, physical activity 
counselling) and the content of the control condition complicated comparison of the studies 
in the review. The timing of the introduction of physical activity also varied across studies, 
with some studies promoting involvement in physical activity several weeks before a quit 
attempt. Almost all studies focused on the use of prescriptive exercise sessions supervised 
by an exercise professional, with only a few promoting changes in daily lifestyle activity as a 
way to manage cigarette cravings and withdrawal symptoms.   
Epidemiological data suggesting that physically active smokers are more likely to attempt to 
quit 19,20 raises the possibility that physical activity could facilitate smoking reduction and 
cessation induction, among those who do not wish to quit immediately.  There are several 
ways in which an increase in physical activity may putatively facilitate smoking reduction 
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and cessation induction 21 including acutely reducing cravings and withdrawal symptoms 22, 
a shift away from a smoking identity 21 and reducing weight gain 23 (all mechanisms which 
may be putatively supported through other behavioural counselling approaches but may be 
further promoted through this innovative approach).  
It is usual for smoking cessation intervention trials to use intention to treat (ITT) analyses  
with an assumption that a participant lost to follow-up is still smoking 24, which essentially 
reflects an assumption of baseline values carried forward. This assumption is problematic if 
it is not correct, as it could potentially bias results and statistical tests in favour of an 
effective treatment if attrition rates are higher in the control group. Also, there is some 
evidence to suggest that those lost to follow-up may not necessarily be smoking 25–29. 
Different approaches to handling missing data on smoking status at follow-up have been 
suggested (e.g. multiple imputation of missing data), which may provide more reliable 
estimates of treatment effects 30–32. 
The data within this article come from a pragmatic pilot randomised controlled trial (RCT) 
assessing the feasibility and acceptability of a counselling based intervention designed to 
support smoking reduction and increases in lifestyle and structured physical activity 
amongst disadvantaged groups. Unique to the current study was the focus on reduction as 
an outcome, without the need to set an abrupt quit date. This was to examine the role of 
reduction to induce quit attempts among those not wishing to quit immediately, which is 
different to other smoking reduction interventions which work to a set quit date 11,13 and 
reflects guidelines on tobacco harm reduction 33. 
We aimed to i) explore the effects of the intervention on smoking and physical activity 
outcomes at 16 weeks compared with controls based on complete case data among 
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disadvantaged smokers (defined as those from social class C2-E (skilled manual workers, 
semi-skilled and unskilled manual workers, and casual or lowest grade workers, pensioners, 
and others who depend on the welfare state for their income), those suffering from an 
indicated mental health problem, and single parents) and ii) conduct secondary analyses to 
explore both the implications of using different approaches to handling missing data and the 
effects this has on outcomes.  
 
METHODS 
More detailed information on the trial methods and intervention development can be found 
elsewhere34. 
Participants 
Ethical approval for the study was granted by the NHS National Research Ethics Service 
Committee South West, in the UK. Recruitment took place in the neighbourhoods of 
Devonport and Stonehouse (Plymouth) which are among the 3% most deprived areas in the 
UK 35. The sample size calculations (via a scenario analysis), recruitment methods, and 
baseline characteristics of the sample, have been reported elsewhere (Taylor et al., 2014). In 
summary, 99 adult moderate to heavy smokers, who wanted to reduce smoking (without 
NRT) but who reported no plans to quit in the next month, were recruited by either a mailed 
invitation from their general practitioner or from NHS Stop Smoking Services (SSS), with 
follow-up telephone calls, or through other community approaches. 
Inclusion/exclusion criteria 
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Participants were eligible to enter the study if they were at least 18 years old, smoked at 
least 10 cigarettes per day (and had done so for at least two years), reported that they did 
not want to quit in the next month but did wish to reduce their smoking, were able to 
engage in moderate intensity physical activity (walk without stopping for at least 15 
minutes), were registered with a GP, and did not wish to use nicotine replacement therapy 
(NRT) to reduce smoking. The study focus was on initially reducing smoking, not quitting, so 
those who expressed an immediate desire to quit were referred directly to the SSS without 
entering the study. Those wishing to use NRT were excluded to avoid any confounding of 
the effects of physical activity on their smoking behaviour. We excluded those with severe 
mental health problems and/or on-going substance misuse due to the potential difficulties 
of engaging them in the intervention given the large uncertai ties and complexities of its 
delivery, and the potential to put the safety of researchers at risk. Given the exploratory 
nature of the study, participants were required to be able to converse in English. These 
criteria were assessed via screening by the researcher, and by approval from interested 
participants’ GPs who confirmed the individual was eligible to enter the study based on the 
provided inclusion/exclusion criteria and did not pose any threat of violence towards the 
researcher in the opinion of the GP. Potential participants could not enter the study until 
approval was obtained. 
Procedures 
After providing informed consent and baseline information, participants were randomised 
via a web-based randomisation programme (provided by the accredited Peninsula Clinical 
Trials Unit) to receive either usual care or usual care plus the Exercise Assisted Reduction 
then Stop smoking (EARS) intervention. Usual care involved  brief advice and information on local 
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SSS for specialist support to quit, as no support was available for smoking reduction as part of 
standard care. The Exercise Assisted Reduction then Stop smoking (EARS) intervention 
consisted of up to 8 weekly client-centred individual motivational support sessions (plus a 
possible further 4 sessions following a quit attempt), via telephone or in person, to assist 
with making self-directed changes in smoking and physical activity behaviour, delivered by a 
team of three Health Trainers 9, plus usual care. The intervention dose was driven by 
participants on the basis of need for further support to reduce.  Those in both arms of the 
study wishing to make a quit attempt throughout the study period were encouraged to seek 
the support of specialist stop smoking services. Full details of the intervention and uptake of 
SSS can be found in the trial’s main report 34. The primary end point was at 16 weeks post 
baseline for the majority of outcomes, except for data on 4 week post-quit expired air 
carbon monoxide (CO) confirmed abstinence which was collected at the appropriate time as 
participants were free to make a quit attempt at any time point in the study. 
Measures 
Given that the study was a pilot RCT we did not formally assign outcomes to be primary or 
secondary. At baseline, 4, 8, and 16 weeks, data were collected  in person (except week 4 
which was collected by telephone) on the number of cigarettes smoked per day (also used 
to calculate percent reduction at 16 weeks), smoking dependence via the Fagerström test 
for cigarette dependence (FTCD) 36,37, expired air CO (Bedfont Smokerlyser, UK) (used to 
calculate expired air CO reduction, not collected at week 4), self-reported physical activity (7 
day recall) 38, and objectively assessed physical activity via accelerometer (Actigraph GT3X, 
Pensacola, USA) (participants were asked to wear the device for 7 days at baseline, week 9, 
and week 16; not collected at week4). Physical activity data collected via self-report were 
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used to calculate total minutes of moderate and vigorous physical activity (MVPA) per week, 
the average minutes of MVPA per day, the number of those completing at least 30 minutes 
of MVPA per day, and the number of those completing at least 150 minutes of MVPA per 
week. Accelerometry data were used to calculate the average minutes of MVPA per day and 
the number of those completing at least 30 minutes of MVPA per day. Quit attempts made 
and 4 week post-quit expired air CO were recorded accordingly throughout the trial with an 
expired air CO reading of <10 parts per million assumed to represent abstinence with self-
reporting not smoking in the past 4 weeks 39.  
Data analyses 
For the primary analyses outcomes were compared between groups based on the principle 
of intention to treat using complete case data.  Multivariate logistic and linear regressions 
were used for binary and continuous outcomes respectively. For secondary intention to 
treat analyses using complete case data plus imputed data, binary smoking outcomes were 
analysed using multivariate logistic regression based on the assumption that participants 
lost to follow up were still smoking at baseline values, and by multiple imputation (chained 
equations); continuous smoking outcomes were analysed by linear regression based on 
baseline values carried forward (BCF), last observation carried forward (LOCF), and by 
multiple imputation chained equations (MICE). For the  MICE analyses, imputation models 
were built for each of the grouped outcomes of binary smoking outcomes, continuos 
smoking outcomes, binary PA outcomes, and continuous smoking outcomes. Predictors 
were selected by those related to missingness and those the research team thought to have 
a priori reason for being linked with missingness, these included: arm, baseline number of 
cigarettes smoked, baseline confidence to quit (high/low), baseline FTCD score, baseline expired air 
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CO, gender, age, 150 minutes  of MVPA per week (yes/no), recruitment method (letter/phonecall), 
HT allocation, and indicated mental health problem. In addition, baseline measure of each outcome 
variable if applicable (e.g. baseline MVPA included for imputing week 16 MVPA). The logit command 
and predictive mean matching (for non-normal continuous variables) were used in imputations. 
Forty imputations were run for each model to reflect the 40% missingness at longest follow up 40.  
Both binary and continuous physical activity outcomes were analysed by linear regression 
based on baseline values carried forward, last observation carried forward, and by MICE. All 
analyses were adjusted for baseline age, gender, FTCD score (all variables which are reliably 
associated with smoking abstinence 14), and Health Trainer allocation (as a minimisation 
factor in randomisation). Imputation models were built for each of the grouped outcomes 
(binary smoking outcomes, continuous smoking outcomes, binary PA outcomes, and 
continuous PA outcomes). All analyses were undertaken in Stata (V.12). 
 
RESULTS 
At 16 weeks, 62% (n=61) of participants provided outcome data, and loss to follow up was 
similar between treatment groups (Figure 1). Intervention participants attended an average 
of 4.2 (SD 2.7) of the 8 available support sessions. Detailed information on factors relating to 
attrition has been reported elsewhere (Thompson et al, under review). 
 
Smoking outcomes 
More participants in the intervention arm (35.5%) than in the control arm (9.7%) made a 
quit attempt at any point in the study (Odd Ratio (OR) 5.05, 95% Confidence Interval (CI): 
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1.10 to 23.15)), and a greater number of participants in the intervention arm (63.3%) 
compared with the control arm (32.3%) achieved at least a 50% reduction in smoking at 16 
weeks (OR:4.21, CI: 1.32 to 13.39)). Secondary sensitivity analyses showed that the 
increased odds of making a quit attempt during the study remained under both assumptions 
of assumed smoking (OR 4.84, CI: 1.1 to 20.31)) and MICE (OR: 5.51, CI: 1.17 to 25.98)). The 
increased odds of achieving a reduction of 50% or more in smoking in the intervention arm 
remained under MICE (OR: 3.48, CI: 1.01 to 12.03)) but not based on the assumption of still 
smoking.  The odds of achieving at least a 25% reduction in expired air CO only showed a 
difference under MICE (OR: 4.11, 95% CI: 1.43 to 11.87)) in the intervention arm (Table 1). 
Primary analyses showed decreases in the adjusted mean difference (95% CI)  on the 
number of self-reported cigarettes smoked per day (-5.14 (-9.09; -1.22)) and FTCD score (-
1.56 (-2.68; -0.43)), and a greater percentage reduction in the number of cigarettes smoked 
(-39.03 (-61.92; -16.15)) in the intervention arm at 16 weeks. Secondary sensitivity analyses 
supported these differences under all assumptions (BCF, LOCF, and MICE; Table 2). 
Physical activity outcomes 
No differences in the odds of achieving any of the physical activity outcomes were shown in 
the primary analyses between arms. Secondary analyses showed increased odds of 
achieving at least 30 minutes of MVPA per day (OR: 2.54, CI: 1.05 to 6.14)) under LOCF, but 
not through BCF or MICE. Increased odds of achieving at least 150 minutes of MVPA per 
week in the intervention arm were shown under LOCF (OR: 3.61, CI: 1.48 to 8.81) and BCF 
(OR: 3.21, CI: 1.33 to 7.77; Table 3). 
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There were no differences in any continuous physical activity outcome, assessed by 
accelerometer or self-report, in the primary or secondary analyses (Table 4). 
 
DISCUSSION 
This article presents data from a trial of a smoking reduction intervention with a focus on 
physical activity among disadvantaged smokers who did not want to initially quit. We 
believe our study is the first of its kind to give insight into the likely cessation induction rates 
for those entering a trial who do not want to quit but then do make a quit attempt, and 
illustrates potential variation in findings resulting from differing intention-to-treat 
assumptions. Whilst the findings were encouraging, the study was exploratory with no a 
priori sample size estimation. Caution is needed in interpreting the results due to the 
relatively small sample size and potential lack of statistical power and precision.  
Individuals in the intervention arm were more likely to initiate a quit attemot when 
compared with those in usual care, suggesting that an intervention designed to support 
reduction could potentially lead to an increase in cessation attempts among those who 
initially had no desire to quit. The trend for greater success in the intervention compared 
with usual care for those achieving a 4 week post-quit CO confirmed quit was promising. 
Along with positive effects of the intervention on reported smoking dependence and the 
amount of cigarettes smoked per day, it would seem that the intervention may impact on a 
variety of smoking outcomes among disadvantaged smokers. 
Secondary analyses showed that the assumption that those lost to follow up were still 
smoking was potentially conservative when compared with the primary complete case 
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analysis or MICE. Despite the conservative nature of this assumption, the assumption that 
loss to follow up meant participants were still smoking only contradicted one finding from 
the primary analyses (i.e., those achieving a reduction of greater than 50% at week 16). It 
thus appears that this assumption has the potential to under-estimate the beneficial effects 
of the intervention 30–32, and although this approach has been widely advocated, more 
research into dealing with missing data in smoking trials is justified. 
Our intervention failed to demonstrate any positive effects on physical activity behaviour at 
16 weeks. Secondary analyses showed increased odds of those in the intervention 
completing 30 minutes of MVPA per day or 150 minutes of MVPA per week compared with 
usual care at 16 weeks. It is likely that the study was underpowered to detect changes in PA 
using only complete case data, but there is some support for increases in PA using 
imputation. Complete case analyses were conservative compared with the three 
approaches to imputation for missing physical activity data, where MICE showed 11% more 
people in the intervention completing 30 minutes of MVPA per day, BCF 17% more, and 
LOCF 19% more compared with only 5% more with complete cases. Similar differences were 
shown for the number of those completing at least 150 minutes of MVPA per week, 
suggesting using only complete case analysis for physical activity data may lead to an 
underestimation of intervention effects. In the present case, it is possible that the 
intervention’s primary focus on smoking reduction meant that increasing physical activity 
was not as well addressed, particularly in regard to longer term maintenance and more 
support is needed to sustain increased PA levels. Disadvantaged groups undertake less 
leisure-time physical activity but undertake more activity associated with work and active 
transport (in part due to low car ownership) 41,42. This relationship clouds an understanding 
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of the effectiveness of interventions to generally increase physical activity 43. Despite 
minimising the focus on doing structured exercise rather than lifestyle physical activity in 
our participant recruitment materials we may have recruited more active smokers resulting 
in a potential ceiling effect when trying to increase physical activity in the intervention. 
Further investigation into physical activity levels among disadvantaged smokers is needed to 
better understand the influence of existing physical activity levels on changing behaviour 
among such groups. 
The pilot aspect of the trial and the current work mean the feasibility of the methods 
employed in analysing the data show promise for application in a larger trial, where more 
confidence in the results could be demonstrated. Due to the relatively low sample size, it 
would be premature to draw any conclusions from this work with a view to influencing 
policy or practice. The trial was pragmatic in that the intervention was as close to what may 
happen in routine intervention delivery as possible. Because of uncertainties about trial 
methods it was designed as a pilot trial to resolve these uncertainties but with the 
opportunity to conduct exploratory analysis on the main outcomes. However, this study 
presents encouraging findings from a pilot pragmatic randomised controlled trial and adds 
to the limited literature on the role of physical activity for smoking reduction, rather than 
abrupt quitting. A fully powered trial to test the effectiveness of a counselling-based 
intervention with a focus on physical activity and smoking reduction among disadvantaged 
groups is now needed. Such a trial should examine the mediating role of changes in physical 
activity on smoking reduction as well as qualitatively explore how physical activity can help 
in self-regulation of smoking. 
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Table 1 Binary smoking outcomes  
 Complete Cases Baseline carried forward Last observation carried forward MICE* 
 Intervention 
(N=30) 
Control 
(N=31) 
Odds ratio† (95% 
CI) 
 
Interventio
n (N=49) 
Control 
(N=50) 
Odds ratio†  (95% 
CI) 
 
Interventio
n (N=49) 
Control 
(N=50) 
Odds ratio† 
(95% CI) 
 
Interventio
n (N=49) 
Control 
(N=50) 
Odds ratio†  (95% 
CI) 
 
Self-reported quit 
attempt during 
study 
 
Yes (n, (%)) 
No (n, (%)) 
 
 
 
 
 
11 (35.5) 
20 (63.5) 
 
 
 
 
  3 (9.7) 
28 (90.3) 
 
 
 
 
5.05 (1.10; 23.15) 
 
 
 
 
11 (22.5) 
38 (77.6) 
 
 
 
 
  3 (6.0) 
47 (94.0) 
 
 
 
 
4.84 (1.15; 20.31) 
 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
16 (32.7) 
33 (67.3) 
 
 
 
 
  5 (10.0) 
45 (90.0) 
 
 
 
 
5.51 (1.17; 25.98) 
Confirmed quit at 4 
weeks post quit-
date 
 
Yes (n, %))  
No (n, (%)) 
 
 
 
 
 
  7 (23.3) 
23 (66.7) 
 
 
 
 
  2 (6.5) 
29 (93.5) 
 
 
 
 
4.91 (0.80; 30.24) 
 
 
 
 
7 (14.3) 
42 (85.7) 
 
 
 
 
  2 (4.0) 
48 (96.0) 
 
 
 
 
4.33 (0.77; 24.39) 
 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
11 (22.4) 
38 (75.6) 
 
 
 
 
  4 (8.0) 
46(92.0) 
 
 
 
 
3.12 (0.60; 16.25) 
Reduction of 
smoking by 50% or 
more by Week 16  
 
Yes (n, (%)) 
No (n, (%)) 
 
 
 
 
 
19 (63.3) 
11 (36.7) 
 
 
 
 
10 (32.3) 
21 (67.7) 
 
 
 
 
4.21 (1.32; 13.39) 
 
 
 
 
19 (38.8) 
30 (61.2) 
 
 
 
 
10 (20.0) 
40 (80.0) 
 
 
 
 
2.51 (0.98; 6.46) 
 
 
 
 
20 (40.8) 
29 (59.2) 
 
 
 
 
12 (24.0) 
38 (76.0) 
 
 
 
 
2.16 (0.87; 5.37) 
 
 
 
 
30 (57.0) 
19(43.0) 
 
 
 
 
15 (30.0) 
35 (60.0) 
 
 
 
 
3.48 (1.01; 12.03) 
Expired air CO of 
≥25% at week 16  
 
 
Yes (n, (%)) 
No (n, (%)) 
 
 
 
 
 
17 (56.6) 
13 (43.4) 
 
 
 
 
21 (67.7) 
10 (32.3) 
 
 
 
 
3.17 (0.98; 10.32) 
 
 
 
 
17 (34.7) 
32 (65.3) 
 
 
 
 
10 (20.0) 
40 (80.0) 
 
 
 
 
2.15 (0.81; 5.71) 
 
 
 
 
17 (34.7) 
32 (65.3) 
 
 
 
 
10 (20.0) 
40 (80.0) 
 
 
 
 
2.15 (0.81; 5.71) 
 
 
 
 
28 (57.1) 
 
 
 
 
15 (30) 
 
 
 
 
4.11 (1.43; 11.87) 
*MICE: Multiple imputation chained equations 
† Adjusted for baseline age, gender, Fagerström Test for Cigarette dependence score, and Health Trainer allocation 
CI: confidence interval; CO: carbon monoxide 
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Table 2 Continuous smoking outcomes  
 Complete Cases Baseline carried forward Last observation carried forward  MICE* 
 Interventio
n 
(N=30) 
Control 
(N=31) 
Difference in 
means† (95% 
CI) 
Intervent
ion 
(N=49) 
Control 
(N=50) 
Difference in 
means† (95% CI) 
 
Intervent
ion 
(N=49) 
Control 
(N=50) 
Difference in 
means† (95% CI) 
 
Intervent
ion 
(N=49) 
Control 
(N=50) 
Difference in 
means† (95% CI) 
Self-reported 
cigarettes per day 
(mean (SD)) 
 
 
9.06 (8.09) 
 
 
13.59 
(7.51) 
 
 
-5.15  
(-9.09; -1.22) 
 
 
12.66 
(9.69) 
 
 
17.59 
(14.01) 
 
 
 
-4.60  
(-9.25; -0.10) 
 
 
11.78 
(8.54) 
 
 
15.42 
(7.35) 
 
 
-3.43  
(-6.46; -0.40) 
 
 
9.25 
(1.42) 
 
 
14.10 
(1.32) 
 
 
-4.78  
(-8.67; -0.91) 
CO (ppm) (mean 
(SD)), n 
 
12.3 (8.31) 
 
15.77 
(7.83) 
 
-3.04  
(-7.18; 1.10) 
 
15.33 
(8.70), 49 
 
16.92 
(8.57), 49 
 
-1.33  
(-4.65; 1.99) 
 
15.51 
(8.85), 49 
 
16.64 
(8.43), 50 
 
-0.96  
(-4.26; 2.33) 
 
13.13 
(1.35) 
 
16.38 
(1.46) 
 
-3.16  
(-6.92; 0.60) 
Amount reduced 
(%) (mean (SD))  
 
-59.70 
(32.54) 
 
-20.13 
(50.10) 
 
-39.03  
(-61.92; -16.15) 
 
-36.55 
(38.78) 
 
-12.48 
(40.42) 
 
-23.08 
 (-38.87; -7.28) 
 
-38.45 
(40.31) 
 
-16.70 
(41.51) 
 
-20.94 
(-37.40; -4.47) 
 
-55.96 
(6.44) 
 
20.74 
(8.85) 
 
-33.49  
(-56.57; -10.41) 
 
FTCD (mean (SD)), 
n 
 
3.09  
(2.20), 22 
 
4.21  
(2.50), 29 
 
-1.56 
 (-2.68; -0.43) 
 
4.27 
(2.22) 
 
5.06  
(2.51) 
 
-0.70  
(-1.38; -0.02) 
 
5.02 
(2.51) 
 
4.04  
(2.28) 
 
-0.89  
(-1.57; -0.21) 
 
2.67 
(0.39) 
 
4.19  
(0.50) 
 
-1.57  
(-2.72; -0.42) 
*MICE: Multiple imputation chained equations 
† Adjusted for baseline age, gender, Fagerström Test for Cigarette dependence score, and Health Trainer allocation  
CI: confidence interval; CO: carbon monoxide; FTCD: Fagerström Test for Cigarette Dependence; ppm: parts per million; SD: standard deviation 
 by guest on M
ay 21, 2015
http://ntr.oxfordjournals.org/
D
ow
nloaded from
 
Ac
ce
pt
ed
 M
an
us
cr
ipt
23 
 
Table 3 Binary physical activity outcomes 
 Complete Cases Baseline carried forward Last observation carried forward MICE* 
 Intervent
ion 
(N=30) 
Control 
(N=31) 
Odds ratio† (95% 
CI) 
Intervent
ion 
(N=49) 
Control 
(N=50) 
Odds ratio† (95% 
CI) 
 
Intervent
ion 
(N=49) 
Control 
(N=50) 
Odds ratio† (95% 
CI) 
 
Intervent
ion 
(N=49) 
Control 
(N=50) 
 
Odds ratio† (95% 
CI) 
Self-report 30 mins MVPA 
per day  
 
Yes (n, (%)) 
No (n, (%)) 
 
 
 
17 (56.7) 
13 (43.3) 
 
 
 
16 (51.6) 
15 (48.4) 
 
 
 
1.31 (0.43; 3.94) 
 
 
 
31 (63.3) 
18 (36.7) 
 
 
 
23 (46.0) 
27 (54.0) 
 
 
 
2.20 (0.93; 5.22) 
 
 
 
31 (63.3) 
18 (36.7) 
 
 
 
22 (44.0) 
28 (56.0) 
 
 
 
2.54 (1.05; 6.14) 
 
 
 
26 (53.1) 
23 (46.9) 
 
 
 
21 (42.0) 
29 (58.0) 
 
 
 
1.37 (0.47; 4.05) 
Self-report >150mins 
MVPA per week  
 
Yes (n, (%)) 
No (n, (%)) 
 
 
 
21 (70.0) 
  9 (30.0) 
 
 
 
16 (51.6) 
15 (48.4) 
 
 
 
2.70 (0.85; 8.58) 
 
 
 
35 (71.4) 
14 (28.6) 
 
 
 
23 (46.0) 
27 (54.0) 
 
 
 
3.21 (1.33; 7.77) 
 
 
 
36 (73.5) 
13 (26.5) 
 
 
 
23 (46.0) 
27 (54.0) 
 
 
 
3.61 (1.48; 8.81) 
 
 
 
33 (67.3) 
16 (32.7) 
 
 
 
21 (42.0) 
29 (58.0) 
 
 
 
3.36 (1.14; 9.93) 
 
 
Accelerometer 30 mins 
MVPA per day 
 
Yes (n, (%)) 
No (n, (%)) 
 
(N=21) 
 
(N=18) 
  
(N=36) 
 
(N=33) 
  
(N=37) 
 
(N=35) 
    
 
 
  8 (38.1) 
13 (61.9) 
 
 
  6 (33.3) 
12 (66.7) 
 
 
1.18 (0.24; 5.68) 
 
 
18 (50.0) 
18 (50.0) 
 
 
15 (45.5) 
18 (54.5) 
 
 
1.52 (0.53; 4.34) 
 
 
18 (48.6) 
19 (51.4) 
 
 
15 (42.9) 
20 (57.1) 
 
 
1.58 (0.57; 4.36) 
 
 
19 (38.8) 
30 (61.2) 
 
 
18 (36.0) 
32 (64.0) 
 
 
1.25 (0.38; 4.11) 
*MICE: Multiple imputation chained equations 
† Adjusted for baseline age, gender, Fagerström Test for Cigarette dependence score, and Health Trainer allocation 
CI: confidence interval; MVPA: moderate and vigorous physical activity 
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Table 4 Continuous physical activity outcomes  
 Complete Cases Baseline carried forward Last observation carried forward MICE* 
 Interventio
n 
(N=30) 
Control 
(N=31) 
Difference in 
means† (95% 
CI) 
Interventio
n (N=49) 
Control 
(N=50) 
Difference in 
means† (95% 
CI) 
 
Interventio
n (N=49) 
Control 
(N=50) 
Difference in 
means† (95% 
CI) 
 
Interventio
n  (N=49) 
Control 
(N=50) 
Difference in 
means† (95% CI) 
Total minutes 
MVPA per week 
(mean (SD)) 
 
 
400.00 
(559.56) 
 
 
378.55 
(514.22) 
 
 
23.53  
(-261.72; 08.78) 
 
 
490.61 
(596.11) 
 
 
309.52 
(444.31) 
 
 
 
185.29  
(-17.89; 388.47) 
 
 
509.49 
(598.41) 
 
 
297.52 
(439.42) 
 
 
220.79  
(19.61; 421.97) 
 
 
435.92 
(576.35) 
 
 
349.85 
(488.08) 
 
 
92.43  
(-188.10; 372.96) 
Total minutes 
MVPA per day 
(mean (SD)) 
 
57.14 
(79.94) 
 
54.08 
(73.89) 
 
3.36  
(-37.39; 44.11) 
 
70.09 
(85.16) 
 
44.22 
(63.47) 
 
26.47 
(-2.56; 55.50) 
 
72.78 
(85.49) 
 
42.50 
(62.77) 
 
31.54  
(2.80; 60.28) 
 
62.27 
(82.34) 
 
49.98 
(69.73) 
 
13.20  
(-26.87; 53.30) 
Accelerometer 
total minutes 
MVPA per day 
(mean (SD), n) 
 
 
27.34 
(21.03), 21 
 
 
26.22 
(19.03), 18 
 
 
0.44  
(-14.40; 15.28) 
 
 
30.60 
(21.22), 33 
 
 
30.79 
(25.10), 36 
 
 
1.95  
(-8.76; 12.65) 
 
 
31.60 
(22.18), 37 
 
 
28.66 
(22.80), 35 
 
 
5.36  
(-4.49; 15.20) 
 
 
26.65 
(20.17), 49 
 
 
25.29 
(18.89), 50 
 
 
1.34 
 (-10.81; 13.50) 
*MICE: Multiple imputation chained equations 
† Adjusted for baseline age, gender, Fagerström Test for Cigarette dependence score, and Health Trainer allocation 
CI: confidence interval; MVPA: moderate and vigorous physical activity; SD: standard deviation 
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Figure 1.  CONSORT chart showing attrition from randomisation through to longest 
follow up 
 
CONSENT RECEIVED/RANDOMISED 
N=99 
Intervention 
n=49 
Control 
n=50 
Week 4 follow-up 
n=38 (34 data sets) 
Lost contact: n =7 
 
Withdrew: n = 5 
• Personal circumstances, 
e.g.illness (n=3) 
• Didn’t want to be in control 
group (n=1) 
• Reason unknown (n=1) 
Week 8 follow-up 
n=33 (29 data sets) 
Week 8 follow-up 
n=35 (31 data sets) 
Week 4 follow-up 
n=40 (35 data sets) 
Week 16 follow-up 
n=30 (full data) 
Week 16 follow-up 
n=31 (full data) 
Lost contact: n=2 
 
Withdrew: n=7 
• Personal circumstances, 
e.g.illness (n=3) 
• Delay prior to intervention 
too long (n=1) 
• Financial reimbursement 
insufficient (n=1) 
• Reason unknown (n=2) 
Lost contact: n=4 
 
Withdrew: n=0 
Lost contact: n=1 
 
Withdrew: n=2 
• Personal circumstances, 
e.g.  illness (n=2) 
Lost contact: n=3 
 
Withdrew: n=0 
Lost contact: n=6 
 
Withdrew: n=1 
• Reason unknown (n=1) 
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